U.S. Colorectal Cancer Therapeutics Market

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Colorectal cancer is a disease of serious magnitude which has escaped national attention and public consciousness. Colorectal cancer leads to a serious societal and individual health burden. The overwhelming majority of patients are above the age of 65 years. With the anticipated demographic changes due to the aging of the baby boomers, the incidence of colorectal cancer will increase in the future. Though colorectal cancer is one of the most preventable cancers if detected early; lack of effective screening tests, patient embarrassment and discomfort over screening and lack of general awareness lead to non-compliance with recommended screening guidelines.

The focus for the future will be to discover the right drug combination which will increase median survival, have a high therapeu

Table of Contents

U.S. Colorectal Cancer Therapeutics Market, Executive SummaryMarket OverviewIntroductionCompetitive AnalysisTechnologiesMajor Research FindingsOpportunitiesMarket Segment Analysis And Revenue ForecastStrategic ConclusionsStrategic RecommendationsU.S. Colorectal Cancer Therapeutics Market, Total MarketOverview and DefinitionsIntroductionChallengesMarket Engineering AnalysisMarket DriversMarket RestraintsForecasts and TrendsDemand AnalysisPricing TrendsRevenue ForecastMarket and Technology TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisStrategic RecommendationsChallenges; Drivers and Restraints ImpactCorporate Management StrategiesResearch and Development StrategiesMarketing StrategiesMarket Engineering AwardsMarket Engineering Leadership-Pharmacia CorporationTechnology Innovation-Matrix Pharmaceutical Inc.Product Line Strategy-Immunomedics Inc.Website Leadership-ImmunexU.S. Colorectal Cancer Therapeutics Market, Chemotherapeutics MarketOverview and DefinitionsIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsForecasts and TrendsRevenue ForecastPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisEmerging ProductsU.S. Colorectal Cancer Therapeutics Market, Immunotherapeutics MarketOverview and DefinitionsIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsForecasts and TrendsPricing TrendsRevenue ForecastCompetitive AnalysisCompetitive StructureEmerging Products-Monoclonal AntibodiesEmerging Products-Other Immunotherapies




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.